Carna Biosciences Inc
TSE:4572
Carna Biosciences Inc
Depreciation & Amortization
Carna Biosciences Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Carna Biosciences Inc
TSE:4572
|
Depreciation & Amortization
¥35.6m
|
CAGR 3-Years
42%
|
CAGR 5-Years
23%
|
CAGR 10-Years
-1%
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Depreciation & Amortization
¥4.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Depreciation & Amortization
¥1.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
Medinet Co Ltd
TSE:2370
|
Depreciation & Amortization
¥109.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-6%
|
|
CellSource Co Ltd
TSE:4880
|
Depreciation & Amortization
¥63.9m
|
CAGR 3-Years
34%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Depreciation & Amortization
¥504.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
43%
|
See Also
What is Carna Biosciences Inc's Depreciation & Amortization?
Depreciation & Amortization
35.6m
JPY
Based on the financial report for Dec 31, 2023, Carna Biosciences Inc's Depreciation & Amortization amounts to 35.6m JPY.
What is Carna Biosciences Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-1%
Over the last year, the Depreciation & Amortization growth was 5%. The average annual Depreciation & Amortization growth rates for Carna Biosciences Inc have been 42% over the past three years , 23% over the past five years , and -1% over the past ten years .